LAG3 and cancer: In the past, significant progress has been made in the discovery of many LAG3 modulators and some of them are currently in the clinic as anticancer drugs, which are summarized in Table 1, involving LAG3-targeted cancer immunotherapy that are either completed, ongoing, or recruiting participants (ClinicalTrials.gov).